The database server is currently not answering requests properly. Some pages are still available due to caching. We are investigating the situation and will keep you updated.

De Novo Variants Disturbing the Transactivation Capacity of POU3F3 Cause a Characteristic Neurodevelopmental Disorder.

Journal: American Journal of Human Genetics

Published: 2019-07-02

DOI: 10.1016/j.ajhg.2019.06.007

Affiliations: 28

Authors: 39

Go to article
Institutions Share
Department of Human Genetics, RU, Netherlands 0.09
IRCCS Bambino Gesù Children's Hospital, Italy 0.08
UMC Department of Medical Genetics, Netherlands 0.08
Ambry Genetics, United States of America (USA) 0.08
Department of Pediatrics, Cornell University, United States of America (USA) 0.05
Faculty / Graduate School of Medicine, YCU, Japan 0.05
Division of Genomic Diagnostics (DGD), CHOP, United States of America (USA) 0.05
New York-Presbyterian Hospital, United States of America (USA) 0.05
Division of Human Genetics, CHOP, United States of America (USA) 0.05
Wellcome Trust Genome Campus, United Kingdom (UK) 0.05
University Hospitals Bristol NHS Foundation Trust (UHBristol), United Kingdom (UK) 0.05
Department of Language and Genetics, Max Planck Institute for Psycholinguistics, Netherlands 0.05
Donders Institute for Brain, Cognition and Behaviour, Netherlands 0.04
Genetics of Development Disorders Team (GAD), France 0.04
Department of Medical Genetics, Osaka Women's and Children's Hospital, Japan 0.03
Dijon University Hospital, France 0.03
Amsterdam UMC, Netherlands 0.03
Center for Molecular and Biomolecular Informatics (CMBI), RU, Netherlands 0.02
Radboud Institute for Molecular Life Sciences (RIMLS), RU, Netherlands 0.02
Institute of Clinical Medicine, UT, Estonia 0.02
Fédération Hospitalo-Universitaire Médecine TRANSLationnelle et Anomalies du Développement (FHU-TRANSLAD), France 0.01
Tartu University Hospital, UT, Estonia 0.01
Division of Genetics and Genomics, BCH, United States of America (USA) 0.01
Division of Neonatology (Newborn Medicine), BCH, United States of America (USA) 0.01
Broad Institute of MIT and Harvard, United States of America (USA) 0.01
School for Oncology and Developmental Biology (GROW), Maastricht UMC+, Netherlands 0.01
Department of Clinical Genetics, Maastricht UMC+, Netherlands 0.01